Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03546192
What this trial is testing

Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 120
Post-approval studies (Phase 4)Study completedNCT03598439
What this trial is testing

Randomized Influenza Vaccine Evaluation of Immune Response

Who this might be right for
Influenza
Marshfield Clinic Research Foundation 366
Post-approval studies (Phase 4)Study completedNCT05648357
What this trial is testing

Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

Who this might be right for
Influenza, Human
GlaxoSmithKline 250
Post-approval studies (Phase 4)WithdrawnNCT03884296
What this trial is testing

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood

Who this might be right for
Influenza
Stanford University
Post-approval studies (Phase 4)Study completedNCT03160118
What this trial is testing

Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults

Who this might be right for
Prevention of Influenza
University Hospital, Ghent 20
Post-approval studies (Phase 4)Study completedNCT04801888
What this trial is testing

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

Who this might be right for
COVID-19Influenza
Sinovac Research and Development Co., Ltd. 480
Large-scale testing (Phase 3)Study completedNCT06049927
What this trial is testing

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 3,300
Post-approval studies (Phase 4)UnknownNCT05480436
What this trial is testing

Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

Who this might be right for
HemolysisCOVID-19
China National Biotec Group Company Limited 1,200
Post-approval studies (Phase 4)Ended earlyNCT03028987
What this trial is testing

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

Who this might be right for
Influenza
Stanford University 10
Not applicableStudy completedNCT04723771
What this trial is testing

Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020

Who this might be right for
Influenza in Human
University of Athens 949
Early research (Phase 1)Study completedNCT03430089
What this trial is testing

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Who this might be right for
InfluenzaFlu
Sanofi Pasteur, a Sanofi Company 101
Testing effectiveness (Phase 2)Study completedNCT05048589
What this trial is testing

Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting

Who this might be right for
Influenza
Tor Biering-Sørensen 12,551
Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Study completedNCT01218646
What this trial is testing

Study of Quadrivalent Influenza Vaccine Among Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 739
Large-scale testing (Phase 3)UnknownNCT05494047
What this trial is testing

Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile

Who this might be right for
InfluenzaVaccines
Pontificia Universidad Catolica de Chile 1,600
Early research (Phase 1)Study completedNCT06342349
What this trial is testing

A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.

Who this might be right for
Influenza
Shanghai Institute Of Biological Products 300
Not applicableStudy completedNCT05406180
What this trial is testing

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above

Who this might be right for
Influenza
Sanofi 675
Large-scale testing (Phase 3)Study completedNCT02621164
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 454
Not applicableStudy completedNCT02663102
What this trial is testing

Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea.

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,388
Post-approval studies (Phase 4)UnknownNCT06208683
What this trial is testing

The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students

Who this might be right for
MumpsInfluenza
Sinovac Biotech Co., Ltd 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation